Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-21-020032
Filing Date
2021-06-16
Accepted
2021-06-16 16:17:53
Documents
1
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5975
  Complete submission text file 0001127602-21-020032.txt   7546
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Issuer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
Alva Emily Peterson (Reporting) CIK: 0001738422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35299 | Film No.: 211021719